CD70-POSITIVE ADVANCED RENAL CLEAR CELL CARCINOMA

Clinical trials for CD70-POSITIVE ADVANCED RENAL CLEAR CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new CD70-POSITIVE ADVANCED RENAL CLEAR CELL CARCINOMA trials appear

Sign up with your email to follow new studies for CD70-POSITIVE ADVANCED RENAL CLEAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

First-in-Human trial launches for experimental CAR-T treatment targeting tough kidney cancer

Disease control Not yet recruiting

This is an early, first-in-human study to test the safety and initial effectiveness of an experimental cell therapy called UCL70805F for patients with advanced kidney cancer. The therapy involves collecting and genetically modifying a patient's own immune cells to target a specif…

Matched conditions: CD70-POSITIVE ADVANCED RENAL CLEAR CELL CARCINOMA

Phase: PHASE1 • Sponsor: UTC Therapeutics Inc. • Aim: Disease control

Last updated Apr 13, 2026 20:20 UTC

CD70-POSITIVE ADVANCED RENAL CLEAR CELL CARCINOMA

Get alerted when new CD70-POSITIVE ADVANCED RENAL CLEAR CELL CARCINOMA trials appear

First-in-Human trial launches for experimental CAR-T treatment targeting tough kidney cancer